Cargando…
Prevention of Early Sudden Cardiac Death after Myocardial Infarction Using the Wearable Cardioverter Defibrillator—Results from a Real-World Cohort
Background: After acute myocardial infarction (AMI), patients are at risk of sudden cardiac death. The VEST trial failed to show a reduction in arrhythmic mortality in AMI patients with an LVEF ≤ 35% prescribed with a WCD, having a lower-than-expected WCD wearing compliance. Objectives: The aim was...
Autores principales: | Rohrer, Ursula, Manninger, Martin, Fiedler, Lukas, Steinwender, Clemens, Binder, Ronald K., Stühlinger, Markus, Zirngast, Birgit, Zweiker, David, Zirlik, Andreas, Scherr, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419414/ https://www.ncbi.nlm.nih.gov/pubmed/37568431 http://dx.doi.org/10.3390/jcm12155029 |
Ejemplares similares
-
Multiparameter Monitoring with a Wearable Cardioverter Defibrillator
por: Rohrer, Ursula, et al.
Publicado: (2021) -
Oversensing of the wearable cardioverter defibrillator during bipolar ventricular stimulation
por: Manninger, Martin, et al.
Publicado: (2017) -
Acute hyperglycaemia is not associated with the development of atrial fibrillation in healthy pigs
por: Manninger, Martin, et al.
Publicado: (2020) -
Physical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator
por: Burch, Ashley E., et al.
Publicado: (2019) -
Automated external defibrillator delivery by a drone in a mountainous region to treat sudden cardiac arrest
por: Fischer, P, et al.
Publicado: (2023)